Zobrazeno 1 - 8
of 8
pro vyhledávání: '"E. Yu. Kitaeva"'
Autor:
K. B. Mirzaev, D. S. Fedorinov, K. A. Akmalova, Sh. P. Abdullaev, A. A. Kachanova, Zh. A. Sozaeva, E. A. Grishina, G. N. Shuev, E. Yu. Kitaeva, V. V. Shprakh, S. Sh. Suleymanov, L. Z. Bolieva, M. S-H. Sozaeva, S. M. Zhuchkova, N. E. Gimaldinova, E. E. Sidukova, I. S. Burashnikova, A. A. Shikaleva, K. G. Zabudskaya, D. A. Sychev
Publikováno v:
Терапевтический архив, Vol 92, Iss 8, Pp 43-51 (2020)
Aim. To study the peculiarities of carrying clinically significant allelic variants of TPMT and DPYD genes associated with the response to drug therapy in cancer practice among 9 ethnic groups of the Russian Federation. Materials and methods. The
Externí odkaz:
https://doaj.org/article/2f106cc4a30443afab05a69a71feda97
Publikováno v:
Pharmacogenetics and Pharmacogenomics. :74-77
Objective. To demonstrate on a clinical example the importance of conducting pharmacogenetic testing in patients with ischemic stroke receiving clopidogrel in order to identify the polymorphic carriage of CYP2C19*17 (C806T, rs12248560). Materials and
Publikováno v:
Clinical pharmacology and therapy. 28:79-84
Autor:
D. A. Sychev, G. N. Shuev, K. A. Akmalova, S. Sh. Suleymanov, Sh. P. Abdullaev, Svetlana Mikhailovna Zhuchkova, Denis S. Fedorinov, Laura Zelimkhanovna Bolieva, Elena A. Grishina, M. S-H. Sozaeva, Zh. A. Sozaeva, A. A. Kachanova, E. Yu. Kitaeva, K. B. Mirzaev, Anastasia Alekseevna Shikaleva, Shprakh Vv, N. E. Gimaldinova, Elena Eduardovna Sidukova, Irina Sergeevna Burashnikova, K. G. Zabudskaya
Publikováno v:
Терапевтический архив, Vol 92, Iss 8, Pp 43-51 (2020)
To study the peculiarities of carrying clinically significant allelic variants of TPMT and DPYD genes associated with the response to drug therapy in cancer practice among 9 ethnic groups of the Russian Federation.The study included 1446 conditionall
Publikováno v:
Clinical Medicine (Russian Journal). 96:677-687
The purpose of this systematic literature review is to highlight the current approach to the issue of “resistance” to antiplatelet drugs, presentation of a personalized approach to antiplatelet therapy in the treatment and secondary prevention of
Autor:
Sh. P. Abdullaev, D.V. Osipova, K. B. Mirzaev, D. A. Sychev, Shprakh Vv, Denis Andreev, E. Yu. Kitaeva
Publikováno v:
Clinical pharmacology and therapy. 27:96-100
Autor:
K.A. Ryzhikova, Yu.A. Pimenova, Shprakh Vv, K. B. Mirzaev, D. A. Sychev, V.K. Kogay, Zh. A. Sozaeva, G. N. Shuev, E. Yu. Kitaeva
Publikováno v:
Siberian Medical Review. :43-50
Publikováno v:
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 119:45
To identify clinical and pharmacogenetic predictors of the efficacy of clopidogrel in patients with AI based on CYP2C19 and ABCB1 genotyping. MATERIAL AND METHODS: Clinical and laboratory examinations were performed in 121 patients with AI, and CYP2C